微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 52.37% | 2.81% | 0.39% | 67/132 | 51.53% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 52.17% | 1.67% | 5.25% | 68/132 | 51.65% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 49.57% | -4.22% | 2.53% | 72/132 | 51.25% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 48.34% | 5.22% | -5.1% | 78/132 | 52.33% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 50.94% | 10.05% | -0.72% | 73/132 | 53.25% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 51.31% | 11.31% | -0.84% | 71/132 | 53.3% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 51.75% | 10.05% | 12.63% | 67/132 | 53.43% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 45.94% | 10.35% | -0.75% | 82/132 | 53.31% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 46.29% | 15.9% | 0.41% | 80/132 | 54.06% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 46.1% | 11.54% | -1.96% | 80/132 | 53.45% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 47.02% | 2% | 12.94% | 79/132 | 53.66% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 41.63% | -3.72% | 4.25% | 92/132 | 53.83% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 39.94% | 2% | -3.36% | 90/132 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.33% | -14.98% | -4.43% | 94/132 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
| 2021-12-31 | 43.24% | -33.34% | -11.04% | 97/132 | 57.29% | 三友医疗 | 90.73% | 行业排名> |
| 2021-06-30 | 48.61% | -32.95% | -25.07% | 80/132 | 58.42% | 三友医疗 | 90.5% | 行业排名> |
| 2020-12-31 | 64.87% | 32.72% | -10.52% | 58/132 | 59.59% | 三友医疗 | 90.29% | 行业排名> |
| 2020-06-30 | 72.5% | 2% | 48.32% | 28/132 | 59.94% | 正海生物 | 90.78% | 行业排名> |
| 2019-12-31 | 48.88% | 2.21% | 2.21% | 73/132 | 56.37% | 正海生物 | 91.59% | 行业排名> |
| 2018-12-31 | 47.82% | 1.67% | 1.67% | 67/132 | 55.53% | 正海生物 | 92.23% | 行业排名> |
| 2017-12-31 | 47.04% | 2% | 2% | 63/132 | 55.34% | 正海生物 | 92.69% | 行业排名> |